Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, oversubscribe...
Builder.ai announced an investment of over $250 million in Series D funding led by Qatar Investment Authority (QIA) taking the total amount raised by ...